The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

Further, we are obliged to ask what is the relevance of these data in a world where the treatment paradigm for endometrial cancer has evolved? Many patients with advanced-stage or recurrent ...

The following is a summary of “Facilitators and Barriers to Acceptability of a Biopsy-First Approach in the Diagnostic ...

Secondary and exploratory analyses of the phase 3 NRG GY018 trial show that, in patients with advanced or recurrent endometrial cancer, first-line treatment with pembrolizumab together with ...